AstraZeneca gets DCGI nod for asthma drug
NEW DELHI: Drug firm AstraZeneca India on Tuesday said it has received marketing authorisation for an asthma drug from the Drugs Controller General of India...
Fasenra
AstraZeneca gets DCGI nod for asthma drug
NEW DELHI: Drug firm AstraZeneca India on Tuesday said it has received marketing authorisation for an asthma drug from the Drugs Controller General of India...
GlaxoSmithKline’s Nucala targets rival AstraZeneca with FDA nod for rare white blood cell disease
GlaxoSmithKline’s immunology leader Nucala has been locked in a yearslong struggle with AstraZeneca’s Fasenra for dominance in rare eosinophilic asthma. With a new rare disease...